Table 3.
Adverse event | 1 day | 1 week | 1 month | 3 months | 6 months |
---|---|---|---|---|---|
Microhyphemaa | 30 (71.4%) | 2 (4.9%) | |||
Hyphemab | |||||
ERM | 1 (2.4%) | ||||
CME | 2 (5.3%) |
Notes:
Microhyphema: suspended red blood cells in the anterior chamber.
Hyphema: layered blood occupying the anterior chamber.
Abbreviations: CME, cystoid macular edema; ERM, epiretinal membrane; phaco-KDB, Kahook Dual Blade combined with phacoemulsification.